Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Use of complementary and alternative medicine in a large sample of anxiety patients.

Bystritsky A, Hovav S, Sherbourne C, Stein MB, Rose RD, Campbell-Sills L, Golinelli D, Sullivan G, Craske MG, Roy-Byrne PP.

Psychosomatics. 2012 May-Jun;53(3):266-72. doi: 10.1016/j.psym.2011.11.009.

2.

Pharmacotherapy of anxiety disorders: a critical review.

Koen N, Stein DJ.

Dialogues Clin Neurosci. 2011;13(4):423-37. Review.

3.

Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness.

Bystritsky A, Nierenberg AA, Feusner JD, Rabinovich M.

J Psychiatr Res. 2012 Apr;46(4):428-35. doi: 10.1016/j.jpsychires.2011.10.013. Review.

PMID:
22261550
4.

The impact of motivational interviewing on resistance in cognitive behavioural therapy for generalized anxiety disorder.

Aviram A, Westra HA.

Psychother Res. 2011 Nov;21(6):698-708. doi: 10.1080/10503307.2011.610832.

PMID:
21878034
5.

Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review.

Sarris J, Camfield D, Berk M.

J Affect Disord. 2012 May;138(3):213-21. doi: 10.1016/j.jad.2011.04.051. Review.

PMID:
21620478
6.

Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?

Roshanaei-Moghaddam B, Pauly MC, Atkins DC, Baldwin SA, Stein MB, Roy-Byrne P.

Depress Anxiety. 2011 Jul;28(7):560-7. doi: 10.1002/da.20829.

PMID:
21608087
7.

Update on repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: different targets.

Blom RM, Figee M, Vulink N, Denys D.

Curr Psychiatry Rep. 2011 Aug;13(4):289-94. doi: 10.1007/s11920-011-0205-3. Review.

8.

Metabolic risk in selected second-generation antipsychotics.

Kerna V, Nosalova G, Ondrejka I.

Bratisl Lek Listy. 2010;111(12):640-3.

PMID:
21384731
9.

Cannabinoids and anxiety.

Moreira FA, Wotjak CT.

Curr Top Behav Neurosci. 2010;2:429-50. Review.

PMID:
21309120
10.

The pharmacology of anxiety.

Durant C, Christmas D, Nutt D.

Curr Top Behav Neurosci. 2010;2:303-30. Review.

PMID:
21309115
11.

Hydroxyzine for generalised anxiety disorder.

Guaiana G, Barbui C, Cipriani A.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006815. doi: 10.1002/14651858.CD006815.pub2. Review.

PMID:
21154375
12.

Kava: a comprehensive review of efficacy, safety, and psychopharmacology.

Sarris J, LaPorte E, Schweitzer I.

Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Review.

PMID:
21073405
13.

The rise of a new GABA pharmacology.

Möhler H.

Neuropharmacology. 2011 Jun;60(7-8):1042-9. doi: 10.1016/j.neuropharm.2010.10.020. Review.

PMID:
21035473
14.

Serotonin receptors - from molecular biology to clinical applications.

Pytliak M, Vargová V, Mechírová V, Felšöci M.

Physiol Res. 2011;60(1):15-25. Review.

15.

Dynamical principles of emotion-cognition interaction: mathematical images of mental disorders.

Rabinovich MI, Muezzinoglu MK, Strigo I, Bystritsky A.

PLoS One. 2010 Sep 21;5(9):e12547. doi: 10.1371/journal.pone.0012547.

16.

Antidepressants: clinically relevant drug interactions to be considered.

Schellander R, Donnerer J.

Pharmacology. 2010;86(4):203-15. doi: 10.1159/000319744. Review.

PMID:
20829645
17.

Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.

Lorenz RA, Jackson CW, Saitz M.

Pharmacotherapy. 2010 Sep;30(9):942-51. doi: 10.1592/phco.30.9.942. Review.

PMID:
20795849
18.

An Internet-based self-help treatment for fear of public speaking: a controlled trial.

Botella C, Gallego MJ, Garcia-Palacios A, Guillen V, Baños RM, Quero S, Alcañiz M.

Cyberpsychol Behav Soc Netw. 2010 Aug;13(4):407-21. doi: 10.1089/cyber.2009.0224.

PMID:
20712499
19.

Current concept of anxiety: implications from Darwin to the DSM-V for the diagnosis of generalized anxiety disorder.

Coutinho FC, Dias GP, do Nascimento Bevilaqua MC, Gardino PF, Pimentel Rangé B, Nardi AE.

Expert Rev Neurother. 2010 Aug;10(8):1307-20. Review.

PMID:
20690210
20.

The pharmacologic treatment of anxiety disorders: a review of progress.

Ravindran LN, Stein MB.

J Clin Psychiatry. 2010 Jul;71(7):839-54. doi: 10.4088/JCP.10r06218blu. Review.

PMID:
20667290
Items per page

Supplemental Content

Support Center